Drugs for HER-2-positive breast cancer
Growth factor receptors have long been known to drive malignant transformation and cancer progression. The epidermal growth factor receptor (EGFR, ErbB, HER) system is likely the best described membrane receptor tyrosine kinase family in malignant tumors. With implementation of the growth-inhibitory...
Na minha lista:
Main Authors: | , , , |
---|---|
格式: | Livro |
語言: | Inglês |
出版: |
Springer,
2011
|
叢編: | Milestones in Drug Therapy, |
主題: | |
在線閱讀: | https://minerva.ufrj.br/F/?func=direct&doc_number=000895504&local_base=UFR01 |
標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|